New implant could offer months of protection from opioid relapse
Disease control
Not yet recruiting
This study is testing a new implant called iSTEP-N, which is placed under the skin and slowly releases a medication (naltrexone) to block the effects of opioids. The goal is to see if this implant can maintain protective drug levels for many months, potentially offering an altern…
Phase: PHASE1 • Sponsor: Akyso Therapeutics, LLC • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC